Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.066 AUD | 0.00% | +1.54% | -18.52% |
Mar. 20 | Australia's Tax Agency Publishes Ruling on Invex Therapeutics' Capital Return | MT |
Feb. 16 | Invex Therapeutics Narrows Fiscal H1 Loss on Lower R&D Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-18.52% | 3.36M | |
+23.50% | 47.07B | |
+47.64% | 42.06B | |
-5.16% | 39.98B | |
+36.37% | 33.02B | |
-7.79% | 27.9B | |
+18.06% | 27.63B | |
+47.29% | 14.37B | |
+41.91% | 13.45B | |
-1.02% | 12.03B |
- Stock Market
- Equities
- IXC Stock
- News Invex Therapeutics Ltd
- Invex Therapeutics Doses First Patient in Phase 3 Neurological Trial; Shares Rise 5%